Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as C$0.11 and last traded at C$0.12, with a volume of 197239 shares. The stock had previously closed at C$0.12.
Nanalysis Scientific Trading Down 4.2%
The company has a quick ratio of 1.11, a current ratio of 1.42 and a debt-to-equity ratio of 71.72. The company has a market cap of C$15.92 million, a P/E ratio of -2.30 and a beta of -0.52. The business has a 50-day moving average price of C$0.14 and a two-hundred day moving average price of C$0.15.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Read More
- Five stocks we like better than Nanalysis Scientific
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
- Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
- After SpaceX, Amazon Could Be The Next Best Space Stock
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
